Zendia

InfectoTest ® – die erste zuverlässige Diagnostik für Malaria

  • Raising on FunderNation
  • Healthcare · Germany

The raise in figures

Raised

€122,250

of €900,000 maximum

13%

of maximum

€0Target €90,000 met€900,000

Investors
41
Minimum investment
€100
Pre-money valuation
€8.8M

At target: €8.8M post-money · 1.02% equity offered

Last updated

↳ FunderNation · checked 2 min ago

About this raise

Zendia is raising money on FunderNation. FunderNation files Zendia under Healthcare; the company is based in Germany.

The round values Zendia at €8.75M pre-money. Its target is €90,000, and its maximum €900,000. It has raised €122,250 from 41 investors so far, which is 13% of its maximum. Investors can put in as little as €100.

For comparison, the 5 other raises in FunderNation’s Healthcare category over the past 12 months had a median target of €150,000 and a median of 63 investors. Zendia’s target of €90,000 is below that median, and with 41 investors so far it has fewer investors than the median raise.

The figures here come from FunderNation, as of Raise Sonar’s last check on .

Live

Close date not published

Funding history

296 readings

Zendia: amount raised over time The amount raised rose from €113,200 on 22 October 2026 to €122,250 on 4 November 2026, over 296 readings. Target €90,000. Maximum €900,000.

The maximum, €900,000, is above the top of the chart.

Zendia: amount raised per day, last 14 days 23 Oct €1,499; 24 Oct €500; 25 Oct €2,650; 26 Oct €100; 27 Oct €0; 28 Oct €2,000; 29 Oct €0; 30 Oct €0; 31 Oct €700; 1 Nov €0; 2 Nov €0; 3 Nov €0; Last 24 hours €0. 23 Oct: €1,49924 Oct: €50025 Oct: €2,65026 Oct: €10027 Oct: €028 Oct: €2,00029 Oct: €030 Oct: €031 Oct: €7001 Nov: €02 Nov: €03 Nov: €0Last 24 hours: €0
Raised €2,700 in the last 7 days; the amount changed too seldom to measure a usual daily pace.

About Zendia

Summarised by Raise Sonar from Zendia’s FunderNation pitch

Zendia develops InfectoTest®, a point-of-care malaria diagnostic that the page says detects infections missed by existing tests, including asymptomatic infections and infections in pregnant women. The company plans to sell single-use sample tubes at €0.80 each on a razor-blade model and sell in bulk to international organisations and national malaria control programmes. The page says clinical validation has been carried out in Uganda, Mali and Angola. This raise is for developing InfectoMixer and InfectoScope prototypes and further clinical validation up to end of 2027.

Read the full pitch on FunderNation (opens in a new tab)

More like this

More raises on FunderNation

All FunderNation raises

Live now

About Raise Sonar

Every live equity crowdfunding raise, in one place

We track raises across Crowdcube, Republic, Wefunder, StartEngine and more, and tell you when they open and before they close.

  • Launch alerts

    An email when a raise matching your filters opens.

  • Close reminders

    Follow a raise and hear from us 72 and 24 hours before it closes.

  • The weekly newsletter

    New raises and raises closing soon, every Monday.